Health News

Dual Rx Therapy Stalled Pancreatic Cancer
Good news on the pancreatic cancer front has been slow for some time now. But the situation may have changed, as a new study suggests that a combination of two medications may improve the outlook for patients whose pancreatic cancer has spread.
Rx May Help Pancreatic Cancer Patients Live Longer
Pancreatic cancer is one of the most difficult to treat cancers. It usually doesn’t give the patient any clues, so it’s generally found later — often when the cancer has spread beyond the pancreas. But results from a recent clinical trial may offer positive news.
New Life For Advanced Cancer Patients
Gemzar (gemcitabine) is the standard of care for pancreatic cancer. Results from a trial showed that adding another medication worked even better.
Asian Pancreatic Cancer Patients Living Longer
A medication that’s used to treat a number of cancers in Japan could help people with pancreatic cancer live longer. The medication has been found to be most beneficial for Asian patients.
Cancer Proves Too Much For Experimental Rx
The theory was solid but, as is so often the case – unfortunately – the experimental drug just didn’t deliver. A phase II trial showed that a new type of chemotherapy wasn’t effective against pancreatic cancer.
Dual Therapies for Treating Pancreatic Cancer
Currently, there's only one chemotherapy agent being used to treat pancreatic cancer. Gemzar (gemcitabine) works for some patients, but not others.